WINDLASPharmaceuticals

Windlas Biotech LtdFinancial Ratios & Key Metrics

736.75
-1.94%
P/E Ratio24.62xIndustry: 31.77x
ROE12.76%Return on equity
ROCE16.96%Return on capital
Debt/Equity0.06Low debt
💎

Valuation & Profitability

P/E Ratio
24.62x
Industry Average P/E
31.77x
Dividend Yield
0.74%
Market Cap
₹1.66K (Cr)
Sales Growth 5Y
18.24%
Profit Growth 5Y
30.32%
EPS Growth 5Y
2.83%
OPM 5Y Avg
12.13%
📉

Price Returns

1 Month
-16.76%
3 Months
-19.02%
6 Months
-14.55%
1 Year
-28.01%
52W Low
697
Current
737
52W High
1140
9% of 52-week range — Near lows
🔬

Technical Indicators

55RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
782
▼ Price below SMA 50 — Bearish
SMA 200
870
▼ Long-term downtrend
Volume Signal
166% of avg
Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.